Class II
Terminated
Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
Why: Presence of Particulate Matter: Silicone oil
- Company
- HOSPIRA INC, LAKE FOREST
LAKE FOREST, IL, United States - Reported
- Aug 16, 2017
- Recall started
- Jul 26, 2017
- Ended
- May 11, 2018
- Where sold
- Nationwide in the USA
- Amount
- 14,300 vials
- Full product description
- Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
- Lots / codes affected
- Lot #: 560053F, Exp. 01AUG2017
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.